Skip to main navigation Skip to search Skip to main content

Recoverin antibody-associated late-onset ataxia without retinopathy

Abstract

Acquired cerebellar ataxia is a rare, in many cases immune-modulated and paraneoplastic illness. Acute and slowly progredient processes are possible. An early treatment is important for a good clinical outcome. Here we present the case of female patient in her 60s with an antirecoverin associated cerebellitis without retinopathia and neoplasia. After an immunosuppressive therapy with steroids and rituximab the symptoms improved, and the progression could be stopped.

Original languageEnglish
Article numbere237479
JournalBMJ Case Reports
Volume13
Issue number12
DOIs
Publication statusPublished - 17.12.2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Dive into the research topics of 'Recoverin antibody-associated late-onset ataxia without retinopathy'. Together they form a unique fingerprint.

Cite this